11. 重症筋無力症 Myasthenia gravis Clinical trials / Disease details

臨床試験数 : 332 / 薬物数 : 234 - (DrugBank : 81) / 標的遺伝子数 : 45 - 標的パスウェイ数 : 127

46 trials found

diseases per page:

Showing 1 to 10 of 46 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2021-002460-46-AT (EUCTR)	16/09/2022	23/05/2022	Evaluating Long-term Safety of EfgartigimodAdministered Intravenously in Children With Generalized M ...	A Long-term, Single-Arm, Open-label, Multicenter, Follow-on Trial of ARGX113-2006 to Evaluate Safety ...	Generalized Myasthenia Gravis MedDRA version: 21.1;Level: PT;Classification code 10028417;Term: Myas ...	Product Name: efgartigimod Product Code: argx-113 INN or Proposed INN: EFGARTIGIMOD ALFA	argenx BV	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	12	Phase 2;Phase 3	France;United States;Canada;Belgium;Spain;Poland;Austria;Georgia;Germany;Netherlands;United Kingdom; ...
2	NCT05374590 (ClinicalTrials.gov)	August 18, 2022	1/4/2022	Evaluating Long-term Safety of EfgartigimodAdministered Intravenously in Children With Generalized M ...	A Long-term, Single-Arm, Open-label, Multicenter, Follow-on Trial of ARGX-113-2006 to Evaluate Safet ...	Generalized Myasthenia Gravis	Biological: Efgartigimod IV	argenx	NULL	Recruiting	2 Years	18 Years	All	12	Phase 2/Phase 3	Netherlands;Poland
3	NCT04777734 (ClinicalTrials.gov)	May 31, 2022	26/2/2021	Efgartigimod Expanded Access for Generalized Myasthenia Gravis	An Expanded Access Program for Efgartigimod Treatment in Patients With Generalized Myasthenia Gravis	Generalized Myasthenia Gravis	Biological: efgartigimod	argenx	NULL	Approved for marketing	18 Years	N/A	All			United States;Austria;Belgium;France;Germany;Italy;Netherlands;Spain
4	EUCTR2020-005841-18-NL (EUCTR)	15/04/2022	19/07/2021	Evaluating the Pharmacokinetics, Pharmacodynamics, and Safety of EfgartigimodAdministered Intravenou ...	Open-label Uncontrolled Trial to Evaluate Pharmacokinetics, Pharmacodynamics, Safety, and Activity o ...	Generalized Myasthenia Gravis MedDRA version: 21.1;Level: PT;Classification code 10028417;Term: Myas ...	Product Name: efgartigimod Product Code: argx-113 INN or Proposed INN: EFGARTIGIMOD ALFA	argenx BV	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	12	Phase 2;Phase 3	France;United States;Canada;Spain;Poland;Belgium;Austria;Georgia;Germany;Netherlands;United Kingdom; ...
5	EUCTR2021-002460-46-ES (EUCTR)	04/04/2022	02/02/2022	Evaluating Long-term Safety of EfgartigimodAdministered Intravenously in Children With Generalized M ...	A Long-term, Single-Arm, Open-label, Multicenter, Follow-on Trial of ARGX113-2006 to Evaluate Safety ...	Generalized Myasthenia Gravis MedDRA version: 21.1;Level: PT;Classification code 10028417;Term: Myas ...	Product Name: efgartigimod Product Code: argx-113 INN or Proposed INN: EFGARTIGIMOD ALFA	argenx BV	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	12	Phase 2;Phase 3	United States;France;Canada;Poland;Belgium;Spain;Austria;Georgia;Netherlands;Germany;United Kingdom; ...
6	EUCTR2020-005841-18-DE (EUCTR)	09/02/2022	30/08/2021	Evaluating the Pharmacokinetics, Pharmacodynamics, and Safety of EfgartigimodAdministered Intravenou ...	Open-label Uncontrolled Trial to Evaluate Pharmacokinetics, Pharmacodynamics, Safety, and Activity o ...	Generalized Myasthenia Gravis MedDRA version: 21.1;Level: PT;Classification code 10028417;Term: Myas ...	Product Name: efgartigimod Product Code: argx-113 INN or Proposed INN: EFGARTIGIMOD ALFA	argenx BV	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	12	Phase 2;Phase 3	France;United States;Canada;Spain;Poland;Belgium;Austria;Georgia;Netherlands;Germany;United Kingdom; ...
7	EUCTR2021-002504-12-IT (EUCTR)	19/01/2022	03/12/2021	A Phase 3b, Randomized, Open-label, Parallel-Group Study to Evaluate Different Dosing Regimens of In ...	A Phase 3b, Randomized, Open-label, Parallel-Group Study to Evaluate Different Dosing Regimens of In ...	Generalized Myasthenia Gravis (gMG) MedDRA version: 20.0;Level: HLT;Classification code 10071942;Ter ...	Product Name: Efgartigimod Product Code: [ARGX-113] INN or Proposed INN: Efgartigimod	ARGENX BV	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	72	Phase 3	France;United States;Canada;Spain;Poland;Belgium;Austria;Georgia;Netherlands;Germany;United Kingdom; ...
8	NCT04980495 (ClinicalTrials.gov)	December 16, 2021	19/7/2021	An Open-label Study to Investigate the Clinical Efficacy of Different Dosing Regimens of Efgartigimo ...	A Phase 3b, Randomized, Open-label, Parallel-Group Study to Evaluate Different Dosing Regimens of In ...	Generalized Myasthenia Gravis	Biological: Efgartigimod concentrate for solution for infusion 20 mg/mL	argenx	NULL	Recruiting	18 Years	N/A	All	72	Phase 3	United States;Austria;Belgium;Canada;France;Georgia;Germany;Italy;Netherlands;Poland;Spain
9	EUCTR2021-002504-12-PL (EUCTR)	01/12/2021	24/09/2021	An open-label study to investigate the clinical efficacy of different dosing regimens of efgartigimo ...	A Phase 3b, Randomized, Open-label, Parallel-Group Study to Evaluate Different Dosing Regimens of In ...	Generalized Myasthenia Gravis (gMG) MedDRA version: 21.1;Level: PT;Classification code 10028417;Term ...	Product Code: ARGX-113 INN or Proposed INN: EFGARTIGIMOD ALFA	argenx BV	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	72	Phase 3	France;United States;Canada;Spain;Belgium;Poland;Austria;Georgia;Netherlands;Germany;United Kingdom; ...
10	EUCTR2020-005841-18-IT (EUCTR)	29/11/2021	25/08/2021	Evaluating the Pharmacokinetics, Pharmacodynamics, and Safety of EfgartigimodAdministered Intravenou ...	Open-label Uncontrolled Trial to Evaluate Pharmacokinetics, Pharmacodynamics, Safety, and Activity o ...	Generalized Myasthenia Gravis MedDRA version: 21.1;Level: PT;Classification code 10028417;Term: Myas ...	Product Name: efgartigimod Product Code: [argx-113] INN or Proposed INN: EFGARTIGIMOD ALFA	ARGENX BV	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	12	Phase 2;Phase 3	France;United States;Canada;Spain;Poland;Belgium;Austria;Georgia;Netherlands;Germany;United Kingdom; ...

First Previous1 2 3 4 5Next Last